Doctor, my biopsy report is ready. What does it actually mean?”
Few documents matter as much in cancer care as your pathology report. For most patients and families, it’s also one of the most confusing — full of unfamiliar terms and abbreviations at a time that already feels overwhelming.
If you’re waiting for your report, or have just received it, you probably have questions. What does it actually tell us? Why does it take so long? If the scan already suggested cancer, why was a biopsy even needed? And what do all those words mean?
This piece will walk you through it.
Why did I need a biopsy if my scan already showed cancer?
This is one of the most common questions patients ask.
Scans like CT, MRI, and PET-CT are remarkable at telling us where something is, how large it is, and whether it may have spread. What they can’t tell us is exactly what it is.
Infections, tuberculosis, inflammation, and even harmless growths can sometimes look like cancer on a scan. And even when a scan strongly suggests cancer, it can’t tell us the exact type — or which treatments are likely to work.
Only a biopsy can answer that.
Think of a scan as viewing a house from the street. You can judge its size and shape, but not how it’s built inside. A biopsy lets us step inside and look at the structure.
That’s why, for almost every patient, treatment planning starts with a biopsy — not a scan.
Why does the report take so long?
Waiting is often the hardest part. Every day feels longer than it is, and it’s natural to worry that nothing is happening while you wait.
In reality, your tissue is going through a careful process. It’s preserved, embedded in wax, sliced thinner than a human hair, mounted on glass slides, stained, and examined under a microscope by a pathologist — a doctor trained specifically to diagnose disease from tissue.
For many cancers, that’s only the first step. Further tests may be needed to identify the proteins or genetic changes driving the cancer — immunohistochemistry (IHC), and in some cancers, next-generation sequencing (NGS).
A routine biopsy report is usually ready in 3 to 7 days, though this varies by hospital and lab. Add IHC, and it may take a few days more. Add NGS, and the complete picture can take two to four weeks, sometimes longer.
It’s frustrating to wait. But in many cancers, the diagnosis genuinely isn’t complete until these results are in — because they’re what let us choose the treatment most likely to work for your cancer, rather than just starting with whatever’s available first.
What is a pathology report, exactly?
It’s the definitive record of what your tissue actually is — prepared by a pathologist, a doctor who specializes in diagnosing disease under the microscope.
As an oncologist, I think of the pathology report as the ground truth of a cancer diagnosis. Scans tell us where the disease is. The pathology report tells us what it is.
Occasionally, a difficult case is reviewed by a specialist pathologist and the reading is refined. Even then, the diagnosis is still made from tissue — the interpretation may shift, but the foundation stays the same.
Every major treatment decision is built on this report.
The parts of the report worth understanding
Pathology reports are written by doctors for doctors. You don’t need to understand every line — but knowing the main sections will help the report make sense when your doctor walks you through it.
The type of cancer. The first and most important question the report answers: what exactly is this? The report names both where the cancer arose and what kind of cancer it is under the microscope. Lung cancer, for example, is first divided into small cell and non-small cell — two types treated as essentially different diseases, even though both start in the lung. The organ tells you where; this second layer tells you what you’re actually up against.
The site is usually inferred from where the biopsy was taken. But not always. Lung, liver, and bone are common sites for cancer to spread to — from a primary cancer elsewhere, say the breast, the intestine, or the prostate. So a biopsy taken from the lung, for instance, can sometimes turn out to be a cancer that originated elsewhere and travelled there, not a lung cancer at all.
Finding out where such a cancer actually originated matters — the organ of origin, not the site it happens to have spread to, is what usually decides the treatment.
A few decades ago, it could be genuinely difficult to determine the site of origin. Today, immunohistochemistry (IHC) — the same test that identifies biomarkers — can usually identify the organ of origin as well, even from a biopsy taken at a site the cancer had spread to.
Tumour grade. Grade describes the cancer’s personality — how the cells look under the microscope, and what that appearance suggests about how the cancer is likely to behave. It says nothing about how far the cancer has spread. Most cancers are graded as low, intermediate, or high grade. Low-grade cancers tend to grow more slowly; high-grade ones tend to grow faster. Some cancers use their own specific scale instead — prostate cancer, for instance, uses the Gleason score. Your doctor will explain what your specific grade means.
Tumour size and margins. If the tumour was surgically removed, the report describes its size and the surgical margins — the edges of the removed tissue. A clear (negative) margin means no cancer cells were seen at the edge, suggesting complete removal. A positive margin means cancer cells reach the edge — this doesn’t automatically mean more surgery, but it factors into whether further treatment is needed.
Lymph nodes. Many cancers spread to nearby lymph nodes before travelling further. If nodes were removed, the report states how many were examined and how many contained cancer — for example, “2 out of 12 lymph nodes positive” means 12 were checked and cancer was found in 2. This feeds directly into staging.
Biomarkers. Often the most important section for your oncologist. Some cancers carry specific proteins or genetic changes that drive their growth — the cancer’s “engine.” Breast cancers, for example, are routinely tested for oestrogen receptors (ER), progesterone receptors (PR), and HER2. These results don’t say anything about how “strong” or “weak” a patient is — they tell us what’s driving that particular cancer, which is what lets treatment become more targeted and more effective.
Grade vs. stage — not the same thing
This trips up a lot of patients.
Grade tells us how aggressive the cancer looks. Stage tells us how far it has spread — usually described with the TNM system: T for tumour size, N for lymph node involvement, M for spread to other organs.
Because they measure different things, they don’t always line up. Someone can have a high-grade cancer caught early (Stage I). Someone else can have a low-grade cancer that’s spread widely (Stage IV). One describes behaviour, the other describes extent — and we need both to choose the right treatment.
Before you search the internet
Many patients receive their report as a printed copy or a PDF over email or WhatsApp — and it’s natural to start Googling every unfamiliar word, or typing the report into an AI chatbot like ChatGPT, Gemini, or Claude and asking it to explain.
I’d encourage you not to. A search engine, or a chatbot, can’t read your report in the context of your age, your health, your scans, or the dozen other factors that shape a treatment decision. It often surfaces outdated information or worst-case scenarios that may not apply to you at all.
Instead: keep a folder with everything — pathology report, IHC report, genetic results, imaging. You’ll need these throughout treatment and follow-up. Read the report, underline what you don’t understand, and bring it to your next appointment — ideally with a family member or friend, since there’s usually a lot to take in.
Explaining what a diagnosis actually means, and how it will be treated, is as much a part of an oncologist’s job as making the diagnosis itself.
Your pathology report isn’t the end of the story. It’s the start of a treatment plan built specifically around your cancer.
Links you may find of use
What is Cancer? A Simple Guide for Patients and Families
https://www.cancer.gov/publications/dictionaries/cancer-terms/def/immunohistochemistry